Combination vaccines in pediatric practice

American Journal of Managed Care

Volumn 9, Issue 1 SUPPL., 2003, Pages

  Lieberman, Jay M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; DIPHTHERIA PERTUSSIS TETANUS RECOMBINANT HEPATITIS B INACTIVATED POLIOMYELITIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED POLIOMYELITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; PEDIARIX; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIPHTHERIA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FEVER; HEALTH CARE COST; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; MANAGED CARE; MEDICAL PRACTICE; NEEDLESTICK INJURY; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; PUBLIC HEALTH; TETANUS; VACCINATION;

EID: 0037269943     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Centers for Disease Control and Prevention. Ten great public health achievements: United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:241-243.
2. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children: United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51:234-237.
3. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287:606-611.
4. Centers for Disease Control and Prevention. Recommended childhood immunization schedule: United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:31-33.
5. Melman ST, Chawla T, Kaplan JM, Anbar RD. Multiple immunizations: Ouch! Arch Fam Med. 1994;3:615-618.
6. Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG. Physician and parent opinions: Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med. 1995;149:845-849.
7. Decker MD, Edwards KM. Combination vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Company; 1999:508-530.
8. Mitchell VS, Philipose NM, Sanford JP, eds. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: National Academy Press; 1993.
9. Pellissier JM, Coplan PM, Jackson LA, May JE. The effect of additional shots on the vaccine administration process: Results of a time-motion study in 2 settings. Am J Manag Care. 2000;6:1038-1044.
10. Pichichero ME. New combination vaccines. Pediatr Clin North Am. 2000;47:407-426.
11. Blatter MM, Reisinger K, Bottenfield GW, et al. Evaluation of the reactogenicity and immunogenicity of a new combined DTPa-HBV-IPV vaccine co-administered with Hib vaccine at 2, 4, & 6 months of age [abstract]. Clin Infect Dis. 1999;29:1074.
12. Gylca R, Gylca V, Benes O, et al. A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. Vaccine. 2001;19:825-833.
13. Schmitt HJ, Knuf M, Ortiz E, et al. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated poliovirus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr. 2000;137:304-312.
14. Usonis V, Bakasenas V. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? Eur J Pediatr. 1999;158:398-402.
15. Yeh SH, Ward JI, Partridge S, et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J. 2001;20:973-980.
16. Zepp F, Schuind A, Meyer C, Sanger R, Kaufhold A, Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics. 2002;109:e58.
17. PEDIARIX Prescribing Information. Philadelphia, Pa: SmithKline Beecham Pharmaceuticals; 2002.